SCREEN TEST SYPHILIS / Sifiliss, 40 gab.
Cena norādīta ar PVN
Rapid test for the diagnosis of Syphilis to qualitatively detect
antibodies (IgG and IgM) to Treponema Pallidum (TP) in whole blood,
serum or plasma. The Syphilis Rapid Test (Whole Blood / Serum / Plasma)
is a qualitative, membrane-based immunoassay for the detection of TP
antibodies (IgG and IgM) in whole blood, serum or plasma. In the
procedure of this test, a recombinant Syphilis antigen is immobilized in
the area of the test line. After the sample is poured into the well
of the holder, it reacts with the Syphilis antigen coated particles in
the test. This compound then migrates upwards on the membrane
chromatographically and reacts with the immobilized Syphilis antigen.
The dual antigen test format can detect both IgG and IgM in samples. If
the sample contains TP antibodies, a colored line will appear in the
test area indicating a positive result. If the sample does not contain
TP antibodies, a colored line will not appear in this area, indicating a
negative result. As a procedural control, a line will always appear in
the test control zone, indicating that the correct volume of specimen
has been used and that the membrane has been soaked. Treponema Pallidum
(TP) is the agent that causes the venereal disease of Syphilis. TP is a
spirochete bacterium with an outer envelope and a cytoplasmic membrane.
Relatively little is known about the organism in comparison to other
pathogenic bacteria. According to the Center for Disease Control (CDC),
the number of cases of Syphilis infection has risen sharply since 1985.
Some key factors that have contributed to this increase include the
prevalence of crack and cocaine and the high incidence of prostitution
among those uses drugs. A study has shown a substantial epidemiological
correlation between the acquisition and transmission of HIV and
Syphilis. Multiple clinical stages and long periods of latent,
asymptomatic infection are characteristic of Syphilis. Primary syphilis
is defined by the presence of a lesion (syphiloma) at the injection
site. The antibody response to the TP bacterium can be detected within
4-7 days after the lesion appears. The infection remains detectable
until the patient receives adequate therapy. The Syphilis Rapid Test
Cassette (Whole Blood/Serum/Plasma) uses a dual antigen combination with
a Syphilis antigen coated particle and a Syphilis antigen immobilized
on a membrane to detect TP antibodies (IgG and IgM) qualitatively and
selectively in blood whole, serum or plasma. The Syphilis Rapid Test
(Whole Blood/Serum/Plasma) is a qualitative, membrane-based immunoassay
for the detection of TP antibodies (IgG and IgM) in whole blood, serum
or plasma. In the procedure of this test, a recombinant Syphilis antigen
is immobilized in the area of the test line. After the sample is
poured into the well of the holder, it reacts with the Syphilis antigen
coated particles in the test. This compound then migrates upwards on the
membrane chromatographically and reacts with the immobilized Syphilis
antigen. The dual antigen test format can detect both IgG and IgM in
samples. If the sample contains TP antibodies, a colored line will
appear in the test area indicating a positive result. If the sample does
not contain TP antibodies, a colored line will not appear in this area,
indicating a negative result. As a procedural control, a line will
always appear in the test control zone, indicating that the correct
volume of specimen has been used and that the membrane has been soaked.
Pirkumu grozs
Pirkumu grozs ir tukšs.